CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company
Atea Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AVIR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 460574869
- Phone
- (857) 284-8891
- Business address
- 225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · New debt or obligation
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Option exercise Director acquired 29,600 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4/A Open-market buy Director bought 6,100 shares at $4.17 ($25,446)
- 4 Open-market buy Director bought 6,100 shares at $4.17 ($25,446)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 1 of 16 · 316 filings